Physician profile
Deepak Bharadia
NPI 1295047645
$4,951.62
in general payments reported to CMS, 2019-2025
15 companies · $1,270 in 2025
The $1,270 reported for 2025 was more than what 75% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $133 · 2021: $281 · 2022: $121 · 2023: $92.70 · 2024: $2,467 · 2025: $1,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,075 · Honoraria: $1,200 · Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,074.76 |
| Honoraria | $1,200.00 |
| Food and Beverage | $555.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $2,816.42 | 2019-2024 | |
| Rti Surgical, INC | $1,224.63 | 2025 | |
| Stryker Corporation | $378.82 | 2019 | |
| Derma Sciences, INC. | $116.93 | 2019 | |
| Acera Surgical, INC. | $95.54 | 2022-2025 | Restrata Wound Matrix |
| Mentor Worldwide LLC | $69.80 | 2024 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Smith+Nephew, INC. | $59.12 | 2022-2023 | Oasis |
| Tela Bio, INC. | $43.10 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $37.75 | 2021 | |
| Mallinckrodt Hospital Products INC. | $31.42 | 2021 | |
| Abbvie INC. | $19.65 | 2023 | Avycaz |
| Sientra, INC. | $18.67 | 2022 | |
| W. L. Gore & Associates, INC. | $17.32 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Kerecis Limited | $11.88 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Musculoskeletal Transplant Foundation INC. | $10.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Bharadia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.